Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.
Torque teno mini virus infection and multiple sclerosis.
Value of NMO-IgG determination at the time of presentation as CIS.
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
Compressive syndrome of internal jugular veins in multiple sclerosis: does it matter?
Potentiation of High Voltage-Activated Calcium Channels by 4-Aminopyridine Depends upon Subunit Composition.
Purkinje cell pathology and loss in multiple sclerosis cerebellum.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
Different mechanisms underlying changes in excitability of peripheral nerve sensory and motor axons in multiple sclerosis.
Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis.
Generation of oligodendroglial cells by direct lineage conversion.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Bioinformatics challenges for genome-wide association studies.
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
Proceedings of the European Charcot Foundation Symposium A Reappraisal of Nutrition and Environment in Multiple Sclerosis, European Charcot Foundation Symposium, December 2-4, 2010, Fiuggi, Italy.
The gut microbiome in multiple sclerosis.
Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination.
The Implication of Vitamin D and Autoimmunity: a Comprehensive Review.
Multiple sclerosis and glutamate excitotoxicity.
Compressive myelopathy: magnetic resonance imaging findings simulating idiopathic acute transverse myelopathy.
Vitamin D and multiple sclerosis: where do we go from here?
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Brain imaging and bladder function.
Pages
« first
‹ previous
…
172
173
174
175
176
177
178
179
180
…
next ›
last »